{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:28:24Z","timestamp":1780579704750,"version":"3.54.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,7,24]],"date-time":"2008-07-24T00:00:00Z","timestamp":1216857600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s00213-008-1237-1","type":"journal-article","created":{"date-parts":[[2008,7,23]],"date-time":"2008-07-23T01:29:16Z","timestamp":1216776556000},"page":"573-583","source":"Crossref","is-referenced-by-count":42,"title":["Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis"],"prefix":"10.1007","volume":"200","author":[{"given":"J\u00f6rg","family":"Daumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Heekeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Neukirch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane M.","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"M\u00f6ller-Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euphrosyne","family":"Gouzoulis-Mayfrank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,7,24]]},"reference":[{"key":"1237_CR1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/hbm.10064","volume":"18","author":"KM Abel","year":"2003","unstructured":"Abel KM, Allin MP, Kucharska-Pietura K, Andrew C, Williams S, David AS, Phillips ML (2003) Ketamine and fMRI BOLD signal: distinguishing between effects mediated by change in cognitive state. Hum Brain Mapp 18:135\u2013145","journal-title":"Hum Brain Mapp"},{"issue":"Suppl 2","key":"1237_CR2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-2007-979354","volume":"31","author":"WM Abi-Saab","year":"1998","unstructured":"Abi-Saab WM, D\u2019Souza DC, Moghaddam B, Krystal JH (1998) The NMDA antagonist model for schizophrenia: promise and pitfalls. Pharmacopsychiatry 31(Suppl 2):104\u2013109","journal-title":"Pharmacopsychiatry"},{"key":"1237_CR3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0920-9964(98)00074-7","volume":"34","author":"J Addington","year":"1998","unstructured":"Addington J, Addington D (1998) Visual attention and symptoms in schizophrenia: a 1-year follow-up. Schizophr Res 34:95\u201399","journal-title":"Schizophr Res"},{"key":"1237_CR4","volume-title":"DSM-IV: diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association (APA)","year":"1994","unstructured":"American Psychiatric Association (APA) (1994) DSM-IV: diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington, DC"},{"key":"1237_CR5","volume-title":"The Scale for the Assessment of Negative Symptoms (SANS)","author":"NC Andreasen","year":"1983","unstructured":"Andreasen NC (1983) The Scale for the Assessment of Negative Symptoms (SANS). The University of Iowa, Iowa City, IA"},{"key":"1237_CR6","volume-title":"The Scale for the Assessment of Positive Symptoms (SAPS)","author":"NC Andreasen","year":"1984","unstructured":"Andreasen NC (1984) The Scale for the Assessment of Positive Symptoms (SAPS). The University of Iowa, Iowa City, IA"},{"key":"1237_CR7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0006-3223(97)00479-4","volume":"44","author":"V Arolt","year":"1998","unstructured":"Arolt V, Teichert HM, Steege D, Lencer R, Heide W (1998) Distinguishing schizophrenic patients from healthy controls by quantitative measurement of eye movement parameters. Biol Psychiatry 44:448\u2013458","journal-title":"Biol Psychiatry"},{"key":"1237_CR8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0730-725X(95)00010-E","volume":"13","author":"NG Burdett","year":"1995","unstructured":"Burdett NG, Menon DK, Carpenter TA, Jones JG, Hall LD (1995) Visualisation of changes in regional cerebral blood flow (rCBF) produced by ketamine using long TE gradient-echo sequences: preliminary results. Magn Reson Imaging 13:549\u2013553","journal-title":"Magn Reson Imaging"},{"key":"1237_CR9","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0006-3223(99)00194-8","volume":"46","author":"WT Carpenter","year":"1999","unstructured":"Carpenter WT (1999) The schizophrenia ketamine challenge study debate. Biol Psychiatry 46:1081\u20131091","journal-title":"Biol Psychiatry"},{"key":"1237_CR10","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0006-3223(92)90117-I","volume":"31","author":"CS Carter","year":"1992","unstructured":"Carter CS, Robertson LC, Chaderjian MR, Celaya LJ, Nordahl TE (1992) Attentional asymmetry in schizophrenia: controlled and automatic processes. Biol Psychiatry 31:909\u2013918","journal-title":"Biol Psychiatry"},{"key":"1237_CR11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0278-5846(94)90075-2","volume":"18","author":"CS Carter","year":"1994","unstructured":"Carter CS, Robertson LC, Chaderjian MR, O\u2019Shora-Celaya L, Nordahl TE (1994) Attentional asymmetry in schizophrenia: the role of illness subtype and symptomatology. Prog Neuropsychopharmacol Biol Psychiatry 18:661\u2013683","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1237_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2003.01693.x","volume":"85","author":"B Dean","year":"2003","unstructured":"Dean B (2003) The cortical serotonin2a receptor and the pathology of schizophrenia: a likely accomplice. J Neurochem 85:1\u201313","journal-title":"J Neurochem"},{"key":"1237_CR13","first-page":"319","volume":"9","author":"A Dittrich","year":"1985","unstructured":"Dittrich A, von Arx S, Staub S (1985) International study on altered states of consciousness (ISASC). Summary of the results. Ger J Psychol 9:319\u2013339","journal-title":"Ger J Psychol"},{"key":"1237_CR14","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0006-3223(99)00209-7","volume":"46","author":"DC D\u2019Souza","year":"1999","unstructured":"D\u2019Souza DC, Berman RM, Krystal JH, Charney DS (1999) Symptom provocation studies in psychiatric disorders: scientific value, risks, and future. Biol Psychiatry 46:1060\u20131080","journal-title":"Biol Psychiatry"},{"key":"1237_CR15","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1152\/jn.00184.2004","volume":"92","author":"JH Fecteau","year":"2004","unstructured":"Fecteau JH, Bell AH, Munoz DP (2004) Neural correlates of the automatic and goal-driven biases in orienting spatial attention. J Neurophysiol 92:1728\u20131737","journal-title":"J Neurophysiol"},{"key":"1237_CR16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00213-005-0154-9","volume":"183","author":"CHY Fu","year":"2005","unstructured":"Fu CHY, Abel KM, Allin MPG, Gasston D, Costafreda SG, Suckling J, Williams SC, McGuire PK (2005) Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: a functional magnetic resonance imaging study. Psychopharmacology 183:92\u2013102","journal-title":"Psychopharmacology"},{"key":"1237_CR17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1037\/0894-4105.13.2.259","volume":"13","author":"LJ Fuentes","year":"1999","unstructured":"Fuentes LJ, Santiago E (1999) Spatial and semantic inhibitory processing in schizophrenia. Neuropsychology 13:259\u2013270","journal-title":"Neuropsychology"},{"key":"1237_CR18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0920-9964(99)00044-4","volume":"40","author":"LJ Fuentes","year":"1999","unstructured":"Fuentes LJ, Boucart M, Alvarez R, Vivas AB, Zimmerman MA (1999) Inhibitory processing in visuospatial attention in healthy adults and schizophrenic patients. Schizophr Res 40:75\u201380","journal-title":"Schizophr Res"},{"key":"1237_CR19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0920-9964(92)90013-U","volume":"7","author":"JM Gold","year":"1992","unstructured":"Gold JM, Randolph C, Coppola R, Carpenter CJ, Goldberg TE, Weinberger DR (1992) Visual orienting in schizophrenia. Schizophr Res 7:203\u2013209","journal-title":"Schizophr Res"},{"issue":"S2","key":"1237_CR20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1055\/s-2007-979348","volume":"31","author":"E Gouzoulis-Mayfrank","year":"1998","unstructured":"Gouzoulis-Mayfrank E, Hermle L, Thelen B, Sass H (1998) History, rationale and potential of experimental hallucinogenic drug research in psychiatry. Pharmacopsychiatry 31(S2):63\u201368","journal-title":"Pharmacopsychiatry"},{"key":"1237_CR21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0893-133X(98)00089-X","volume":"20","author":"E Gouzoulis-Mayfrank","year":"1999","unstructured":"Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, Arning C, Thelen B, Spitzer M, Kovar KA, B\u00fcll U, Sass H (1999) Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG. Neuropsychopharmacology 20:565\u2013581","journal-title":"Neuropsychopharmacology"},{"key":"1237_CR22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.pnpbp.2003.11.010","volume":"28","author":"E Gouzoulis-Mayfrank","year":"2004","unstructured":"Gouzoulis-Mayfrank E, Heekeren K, Voss T, Moerth D, Thelen B, Meincke U (2004) Blunted inhibion of return (IOR)\u2014a trait marker of schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry 28:389\u2013396","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1237_CR23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2005-916185","volume":"38","author":"E Gouzoulis-Mayfrank","year":"2005","unstructured":"Gouzoulis-Mayfrank E, Heekeren K, Timmerbeil A, Stoll M, Stock C, Obradovic M, Kovar K-A (2005) Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers. Pharmacopsychiatry 38:301\u2013311","journal-title":"Pharmacopsychiatry"},{"key":"1237_CR24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pnpbp.2005.06.016","volume":"30","author":"E Gouzoulis-Mayfrank","year":"2006","unstructured":"Gouzoulis-Mayfrank E, Arnold S, Heekeren K (2006a) Deficient inhibition of return in schizophrenia\u2014further evidence from an independent sample. Prog Neuropsychopharmacol Biol Psychiatry 30:42\u201349","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1237_CR25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.npp.1300882","volume":"31","author":"E Gouzoulis-Mayfrank","year":"2006","unstructured":"Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, Daumann J, Obradovic M, Kovar KA (2006b) Inhibition of return in the human 5-HT2A agonist and NMDA antagonist model of psychosis. Neuropsychopharmacology 31:431\u2013441","journal-title":"Neuropsychopharmacology"},{"key":"1237_CR26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.schres.2007.06.028","volume":"97","author":"E Gouzoulis-Mayfrank","year":"2007","unstructured":"Gouzoulis-Mayfrank E, Balke M, Hajsamou S, Ruhrmann S, Schultze-Luther F, Daumann J, Heekeren K (2007) Orienting of attention in unmedicated patients with schizophrenia, prodromal subjects and healthy relatives. Schizophr Res 97:35\u201342","journal-title":"Schizophr Res"},{"key":"1237_CR27","doi-asserted-by":"crossref","first-page":"12085","DOI":"10.1073\/pnas.96.21.12085","volume":"96","author":"T Grunwald","year":"1999","unstructured":"Grunwald T, Beck H, Lehnertz K, Bl\u00fcmcke I, Pezer N, Kurthen M, Fernandez G, Van Roost D, Heinze HJ, Kutas M, Elger CE (1999) Evidence relating human verbal memory to hippocampal N-methyl-d-aspartate receptors. Proc Natl Acad Sci U S A 96:12085\u201312089","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1237_CR28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.mp.4001558","volume":"10","author":"PJ Harrison","year":"2005","unstructured":"Harrison PJ, Weinberger DR (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10:40\u201368","journal-title":"Mol Psychiatry"},{"key":"1237_CR29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0074-7742(08)60558-9","volume":"27","author":"PS Holzman","year":"1985","unstructured":"Holzman PS (1985) Eye movement dysfunctions and psychosis. Int Rev Neurobiol 27:179\u2013205","journal-title":"Int Rev Neurobiol"},{"key":"1237_CR30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00213-005-0001-z","volume":"181","author":"GD Honey","year":"2004","unstructured":"Honey GD, Honey RAE, Sharar SR, Turner DC, Pomarol-Clotet E, Kumaran D, Simons JS, Hu X, Rugg MD, Bullmore ET, Fletcher PC (2004) Impairment of specific episodic memory processes by sub-psychotic doses of ketamine: the effects of levels of processing at encoding and of subsequent retrieval task. Psychopharmacology 181:445\u2013457","journal-title":"Psychopharmacology"},{"key":"1237_CR31","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/sj.npp.1300438","volume":"29","author":"RAE Honey","year":"2005","unstructured":"Honey RAE, Honey GD, O\u2019Loughlin C, Sharar SR, Kumaran D, Bullmore ET, Menon DK, Donovan T, Lupson VC, Bisbrown-Chippendale R, Fletcher PC (2005) Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: an fMRI study. Neuropsychopharmacology 29:1203\u20131214","journal-title":"Neuropsychopharmacology"},{"key":"1237_CR32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00023210-200620050-00004","volume":"20","author":"J Horacek","year":"2006","unstructured":"Horacek J, Bubenikova-Valesova V, Kopecek M, Palenicek T, Dockery C, Mohr P, Hoschl C (2006) Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs 20:389\u2013409","journal-title":"CNS Drugs"},{"key":"1237_CR33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0920-9964(94)90009-4","volume":"14","author":"ED Huey","year":"1994","unstructured":"Huey ED, Wexler BE (1994) Abnormalities in rapid, automatic aspects of attention in schizophrenia: blunted inhibition of return. Schizophr Res 14:57\u201363","journal-title":"Schizophr Res"},{"key":"1237_CR34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuroimage.2003.09.026","volume":"21","author":"HE Hulshoff Pol","year":"2004","unstructured":"Hulshoff Pol HE, Schnack HG, Mandl RC, Cahn W, Collins DL, Evans AC, Kahn RS (2004) Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity. NeuroImage 21:27\u201335","journal-title":"NeuroImage"},{"key":"1237_CR35","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","volume":"148","author":"DC Javitt","year":"1991","unstructured":"Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301\u20131308","journal-title":"Am J Psychiatry"},{"key":"1237_CR36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/sj.mp.4001093","volume":"7","author":"S Kapur","year":"2002","unstructured":"Kapur S, Seeman P (2002) NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors\u2014implications for models of schizophrenia. Mol Psychiatry 7:837\u2013844","journal-title":"Mol Psychiatry"},{"key":"1237_CR37","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0304-3940(80)90178-0","volume":"20","author":"JS Kim","year":"1980","unstructured":"Kim JS, Kornhuber HH, Schmid-Burgk W, Holzm\u00fcller B (1980) Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 20:379\u2013382","journal-title":"Neurosci Lett"},{"key":"1237_CR38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1364-6613(00)01452-2","volume":"4","author":"RM Klein","year":"2000","unstructured":"Klein RM (2000) Inhibition of return. Trends Cogn Sci 4:138\u2013147","journal-title":"Trends Cogn Sci"},{"key":"1237_CR39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0163-7258(02)00328-5","volume":"97","author":"C Konradi","year":"2003","unstructured":"Konradi C, Heckers S (2003) Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol Ther 97:153\u2013179","journal-title":"Pharmacol Ther"},{"key":"1237_CR40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","volume":"51","author":"JH Krystal","year":"1994","unstructured":"Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humansPsychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199\u2013214","journal-title":"Arch Gen Psychiatry"},{"key":"1237_CR41","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0278-5846(01)00298-6","volume":"26","author":"A Larrison-Faucher","year":"2002","unstructured":"Larrison-Faucher A, Briand KA, Sereno AB (2002) Delayed onset of inhibition of return in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 26:505\u2013512","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1237_CR42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1162\/089892902317236795","volume":"14","author":"J Lepsien","year":"2002","unstructured":"Lepsien J, Pollmann S (2002) Covert reorienting and inhibition of return: an event-related fMRI study. J Cogn Neurosci 14:127\u2013144","journal-title":"J Cogn Neurosci"},{"key":"1237_CR43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0022-3956(93)90056-8","volume":"27","author":"M Liotti","year":"1993","unstructured":"Liotti M, Dazzi S, Umilta C (1993) Deficits of the automatic orienting of attention in schizophrenic patients. J Psychiatr Res 27:119\u2013130","journal-title":"J Psychiatr Res"},{"key":"1237_CR44","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1017\/S0033291798007132","volume":"28","author":"P Maruff","year":"1998","unstructured":"Maruff P, Danckert J, Pantelis C, Currie J (1998) Saccadic and attentional abnormalities in patients with schizophrenia. Psychol Med 28:1091\u20131100","journal-title":"Psychol Med"},{"key":"1237_CR45","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuroimage.2004.06.027","volume":"23","author":"AR Mayer","year":"2004","unstructured":"Mayer AR, Dorflinger JM, Rao SM, Seidenberg M (2004a) Neural networks underlying endogenous and exogenous visual-spatial orienting. NeuroImage 23:534\u2013541","journal-title":"NeuroImage"},{"key":"1237_CR46","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1162\/0898929041920531","volume":"16","author":"AR Mayer","year":"2004","unstructured":"Mayer AR, Seidenberg M, Dorflinger JM, Rao SM (2004b) An event-related fMRI study of exogenous orienting: supporting evidence for the cortical basis of inhibition of return? J Cogn Neurosci 16:1262\u20131271","journal-title":"J Cogn Neurosci"},{"key":"1237_CR47","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1176\/appi.ajp.158.11.1809","volume":"158","author":"A Meyer-Lindenberg","year":"2001","unstructured":"Meyer-Lindenberg A, Poline JB, Kohn PD, Holt JL, Egan MF, Weinberger DR, Berman KF (2001) Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am J Psychiatry 158:1809\u20131817","journal-title":"Am J Psychiatry"},{"key":"1237_CR48","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"B Moghaddam","year":"1997","unstructured":"Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921\u20132927","journal-title":"J Neurosci"},{"key":"1237_CR49","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1162\/jocn.2007.19.4.587","volume":"19","author":"NG M\u00fcller","year":"2007","unstructured":"M\u00fcller NG, Kleinschmidt A (2007) Temporal dynamics of the attentional spolight: neuronal correlates of attentional capture and inhibition of return in early visual cortex. J Cogn Neurosci 19:587\u2013593","journal-title":"J Cogn Neurosci"},{"key":"1237_CR50","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.schres.2004.04.009","volume":"72","author":"G Northoff","year":"2005","unstructured":"Northoff G, Richter A, Bermpohl F, Grimm S, Martin E, Marcar VL, Wahl C, Hell D, Boeker H (2005) NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI. Schizophr Res 72:235\u2013248","journal-title":"Schizophr Res"},{"key":"1237_CR51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0920-9964(98)00092-9","volume":"34","author":"M Oie","year":"1998","unstructured":"Oie M, Rund BR, Sundet K (1998) Covert visual attention in patients with early-onset schizophrenia. Schizophr Res 34:195\u2013205","journal-title":"Schizophr Res"},{"key":"1237_CR52","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799\u2013812","journal-title":"Psychol Rep"},{"key":"1237_CR53","first-page":"381","volume-title":"NMDA receptor related agents: biochemistry, pharmacology and behavior","author":"N \u00d8ye","year":"1991","unstructured":"\u00d8ye N, Hustveit O, Moberg ER, Pausen O, Skoglund LA (1991) The chiral forms of ketamine as probes for NMDA receptor function in humans. In: Kameyama T, Nabeshima T, Domino ES (eds) NMDA receptor related agents: biochemistry, pharmacology and behavior. Ann Arbor, NPP Books, pp 381\u2013389"},{"key":"1237_CR54","first-page":"1209","volume":"260","author":"N \u00d8ye","year":"1992","unstructured":"\u00d8ye N, Paulsen O, Maurset A (1992) Effects of ketamine on sensory perception: evidence for a roel of N-methyl-d-aspartate receptors. J Pharmacol Exp Ther 260:1209\u20131213","journal-title":"J Pharmacol Exp Ther"},{"key":"1237_CR55","first-page":"531","volume-title":"Attention and performance. Control of language processing","author":"MI Posner","year":"1984","unstructured":"Posner MI, Cohen Y (1984) Components of visual orienting. In: Bouma H, Bouwhuis DG (eds) Attention and performance. Control of language processing. Erlbaum, London, pp 531\u2013556"},{"key":"1237_CR56","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/archpsyc.1988.01800330038004","volume":"45","author":"MI Posner","year":"1988","unstructured":"Posner MI, Early TS, Reiman E, Pardo PJ, Dhawan M (1988) Asymmetries in hemispheric control of attention in schizophrenia. Arch Gen Psychiatry 45:814\u2013821","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"1237_CR57","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1037\/0096-1523.15.4.673","volume":"15","author":"RD Rafal","year":"1989","unstructured":"Rafal RD, Calabresi PA, Brennan CW, Sciolto TK (1989) Saccade preparation inhibits reorienting to recently attended locations. J Exp Psychol Hum Percept Perform 15(4):673\u2013685","journal-title":"J Exp Psychol Hum Percept Perform"},{"key":"1237_CR58","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1176\/appi.ajp.161.6.1004","volume":"161","author":"JD Ragland","year":"2004","unstructured":"Ragland JD, Gur RC, Valdez J, Turetsky BI, Elliott M, Kohler C, Siegel S, Kanes S, Gur RE (2004) Event-related fMRI of frontotemporal activity during word encoding and recognition in schizophrenia. Am J Psychiatry 161:1004\u20131015","journal-title":"Am J Psychiatry"},{"key":"1237_CR59","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1162\/089892999563283","volume":"11","author":"AC Rosen","year":"1999","unstructured":"Rosen AC, Rao SM, Caffarra P, Scaglioni A, Bobholz JA, Woodley SJ, Hammeke TA, Cunningham JM, Prieto TE, Binder JR (1999) Neural basis of endogenous and exogenous spatial orienting. A functional MRI study. J Cogn Neurosci 11:135\u2013152","journal-title":"J Cogn Neurosci"},{"key":"1237_CR60","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/15977","volume":"2","author":"A Sapir","year":"1999","unstructured":"Sapir A, Soroker N, Berger A, Henik A (1999) Inhibition of return in spatial attention: direct evidence for collicular generation. Nat Neurosci 2:1053\u20131054","journal-title":"Nat Neurosci"},{"key":"1237_CR61","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1037\/0894-4105.15.3.361","volume":"15","author":"A Sapir","year":"2001","unstructured":"Sapir A, Henik A, Dobrusin M, Hochman EY (2001) Attentional asymmetry in schizophrenia: disengagement and inhibition of return deficits. Neuropsychology 15:361\u2013370","journal-title":"Neuropsychology"},{"key":"1237_CR62","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1053-8119(03)00106-X","volume":"19","author":"R Schlosser","year":"2003","unstructured":"Schlosser R, Gesierich T, Kaufmann B, Vucurevic G, Hunsche S, Gawehn J, Stoeter P (2003) Altered effective connectivity during working memory performance in schizophrenia: a study with fMRI and structural equation modeling. NeuroImage 19:751\u2013763","journal-title":"NeuroImage"},{"key":"1237_CR63","volume-title":"Schizophrenia proneness instrument, adult version (SPI-A)","author":"F Schultze-Lutter","year":"2007","unstructured":"Schultze-Lutter F, Addington J, Ruhrmann S, Klosterkotter J (2007) Schizophrenia proneness instrument, adult version (SPI-A). Giovanni Fioriti Editore s.r.l, Rome, Italy"},{"key":"1237_CR64","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0006-3223(94)00127-O","volume":"37","author":"AB Sereno","year":"1995","unstructured":"Sereno AB, Holzman PS (1995) Antisaccades and smooth pursuit eye movements in schizophrenia. Biol Psychiatry 37:394\u2013401","journal-title":"Biol Psychiatry"},{"key":"1237_CR65","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0893-133X(88)90016-4","volume":"1","author":"SH Snyder","year":"1988","unstructured":"Snyder SH (1988) Psychotogenic drugs as models for schizophrenia. Neuropsychopharmacology 1:197\u2013199","journal-title":"Neuropsychopharmacology"},{"key":"1237_CR66","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archpsyc.1994.03950020022002","volume":"51","author":"RJ Strassman","year":"1994","unstructured":"Strassman RJ, Qualls CR, Uhlenhuth EH, Kellner R (1994) Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Arch Gen Psychiatry 51:98\u2013108","journal-title":"Arch Gen Psychiatry"},{"key":"1237_CR67","first-page":"139","volume":"37","author":"ME Strauss","year":"1991","unstructured":"Strauss ME, Novakovic T, Tien AY, Bylsma F, Pearlson GD (1991) Disengagement of attention in schizophrenia. Schizophr Res 37:139\u2013146","journal-title":"Schizophr Res"},{"key":"1237_CR68","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0165-1781(92)90144-R","volume":"43","author":"ME Strauss","year":"1992","unstructured":"Strauss ME, Alphs L, Boekamp J (1992) Disengagement of attention in chronic schizophrenia. Psychiatry Res 43:87\u201392","journal-title":"Psychiatry Res"},{"key":"1237_CR69","volume-title":"Co-planar stereotactic atlas of the human brain","author":"J Talairach","year":"1988","unstructured":"Talairach J, Tournaoux P (1988) Co-planar stereotactic atlas of the human brain. Thieme, Stuttgart"},{"key":"1237_CR70","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.pharmtox.42.082701.160735","volume":"42","author":"G Tsai","year":"2002","unstructured":"Tsai G, Coyle JT (2002) Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol 42:165\u2013179","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1237_CR71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0924-977X(96)00042-9","volume":"7","author":"FX Vollenweider","year":"1997","unstructured":"Vollenweider FX, Antonini A, Leenders KL, Oye I, Hell D, Angst J (1997) Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET). Eur Neuropsychopharmacol 7:25\u201338","journal-title":"Eur Neuropsychopharmacol"},{"key":"1237_CR72","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-3956(99)00031-X","volume":"34","author":"FX Vollenweider","year":"2000","unstructured":"Vollenweider FX, Vontobel P, Oye I, Hell D, Leenders KL (2000) Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans. J Psychiatr Res 34:35\u201343","journal-title":"J Psychiatr Res"},{"key":"1237_CR73","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archpsyc.1986.01800020020004","volume":"43","author":"DR Weinberger","year":"1986","unstructured":"Weinberger DR, Berman KF, Zec RF (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 43:114\u2013124","journal-title":"Arch Gen Psychiatry"},{"key":"1237_CR74","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0006-3223(01)01252-5","volume":"50","author":"DR Weinberger","year":"2001","unstructured":"Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, Berman KF, Goldberg TE (2001) Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 50:825\u2013844","journal-title":"Biol Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1237-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-008-1237-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1237-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:06:43Z","timestamp":1558642003000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-008-1237-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,24]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["1237"],"URL":"https:\/\/doi.org\/10.1007\/s00213-008-1237-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,24]]}}}